{"name":"Animuscure Inc.","slug":"animuscure-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE90ZzBnNlV3RHpBR0RmaDAtTEthQ2NKT3ZPcUtkbkNIRFZZelZmQmVMZHNhYnRVTUFDYjMwdU1YVXJCZm9Ya0ViUzNNS3hGcXRwNVE?oc=5","date":"2025-10-17","type":"pipeline","source":"매일경제","summary":"AnimusCure, a teacher start-up company at Sookmyung Women's University, announced on the 17th that i.. - 매일경제","headline":"AnimusCure, a teacher start-up company at Sookmyung Women's University, announced on the 17th that i.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9abjNsak1IWmpWeEpWRnlFdnMxTjEtZEhjVVM3UTRtR3FVeks1UmpIMnpBang3LTY1WXNrenBGamlHRzBfamhxalJjV1B1eVNTM0lWZXB2UVU2TzR4alN4bHRjLXNuTTBKOU00ZF93Z3hpcER2NzJhQm8wdw?oc=5","date":"2025-03-26","type":"pipeline","source":"Wiley","summary":"PRMT1 Ablation in Endothelial Cells Causes Endothelial Dysfunction and Aggravates COPD Attributable to Dysregulated NF-κB Signaling - Wiley","headline":"PRMT1 Ablation in Endothelial Cells Causes Endothelial Dysfunction and Aggravates COPD Attributable to Dysregulated NF-κ","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}